Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	n.A.	-2.74	n.A.
Graham Fair Price	100.00	0.38	0.00
PEG	100.00	< 0.005	0.00
Price/Book	100.00	0.44	0.00
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	-100.00	-2.28	0.00
Price/Sales	100.00	0.36	0.00
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	125.31	0.09	0.04
Operating Margin	229.09	-0.04	0.01
ROA	-100.00	-0.02	0.00
ROE	0.00	-0.05	-100.00
ROIC	0.00	-0.04	-100.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	-3.13	-100.00
EPS QOQ	0.00	-3.62	-100.00
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.00	-0.35	-100.00
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	n.A.	49.65	n.A.
Days Sales Outstanding (DSO)	n.A.	57.58	n.A.
Inventory Turnover	0.00	1.81	100.00
Debt/Capitalization	0.00	0.22	100.00
Quick Ratio	0.00	0.93	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.00	0.37	100.00
Cash	0.00	0.30	100.00
Capex	0.00	0.00	0.00
Free Cash Flow	0.00	0.00	0.00
Revenue	0.00	0.45	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.00	1.39	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	n.A.	-15.66	n.A.
Naive Interpretation	Member

06 - Financial Health · Weak

Rating